A judge recently ruled that pharmaceutical company Merck & Co must release its email exchanges concerning its shingles vaccine, Zostavax.
More than 1,800 lawsuits filed against Merck & Co combined into a multidistrict litigation, and the plaintiffs accuse the company of changing label information on their vaccine. Plaintiffs claim this caused them severe injuries. It has yet to be announced what information plaintiffs believe Merck & Co changed on the label.
The judge ruled that nearly all of the documents in question should be released.